Potential to enhance the prescribing of generic drugs in patients with mental health problems in Austria; implications for the future
Introduction: Scrutiny over pharmaceutical expenditure is increasing leading to multiple reforms. This includes Austria with measures to lower generic prices and enhance their utilisation. However the situation for newer antidepressants and atypical antipsychotic drugs (AAPs) is different to PPIs, s...
Saved in:
Main Authors: | Brian eGodman (Author), Thomas eBurkhardt (Author), Anna eBucsics (Author), Jutta ePiessnegger (Author), Manuela eSchmitzer (Author), Corrado eBarbui (Author), Marion eBennie (Author), Lars L Gustafsson (Author), Emanuel eRaschi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different initiatives across Europe to enhance losartan utilisation post generics: impact and implications
by: James eMoon, et al.
Published: (2014) -
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
by: Brian eGodman, et al.
Published: (2014) -
Policies to enhance prescribing efficiency in Europe: findings and future implications
by: Brian eGodman, et al.
Published: (2011) -
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimise the use of new drugs
by: Rickard eMalmstrom, et al.
Published: (2013) -
Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals - comparison of Austria and Finland
by: Jaana E Martikainen, et al.
Published: (2015)